Institutional Review Board, Hospital for Special Surgery
March 06, 2007
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Sean Wilson
We will enroll patients of Dr. Robert Marx who undergo ACL reconstruction surgery. Approximately 150 patients will be enrolled. Patients receive follow up questionnaires at two, six and ten years after their surgery.
Exclusion criteria:
Robert Marx MD
212.606.1645
Research Coordinator:
Sean Wilson
646. 797.8411
wilsonse@hss.edu